Pfizer Inc.

09/16/2024 | Press release | Distributed by Public on 09/15/2024 22:21

Pfizer’s BRAFTOVI® + MEKTOVI® Shows Long Term Clinically Meaningful Response in Patients with BRAF V600E Mutant Metastatic Non Small Cell Lung Cancer